Skip to content

Clinical trials

Phase 1/2 Diabetes Mellitus, Type 2 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 1/2 Clear all

113 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20042
20058
20062
20076
20085
20094
20108
20119
20125
20139
20146
20153
20163
20173
20182
20193
20203
20212
20227
20236
20244
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Unknown status21
Recruiting8
Terminated8
Active, not recruiting6
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis4
Hanoi Medical University3
Novartis Pharmaceuticals3
Alnylam Pharmaceuticals2
AstraZeneca2
Boston Medical Center2
Brigham and Women's Hospital2
Elcelyx Therapeutics, Inc.2
Fuzhou General Hospital2
Mesoblast, Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2113
Diabetes Mellitus29
Insulin Resistance16
Obesity15
Diabetes Mellitus, Type 15
Hypertension3
Inflammation3
Non-alcoholic Fatty Liver Disease3
Overweight3
Weight Loss3

Trials

Showing 26 to 50 of 113. Each trial links to its page on Pharma Observatory.

13 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.